{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:46:14Z","timestamp":1773189974061,"version":"3.50.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,4,18]],"date-time":"2008-04-18T00:00:00Z","timestamp":1208476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s11102-008-0121-7","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T05:35:24Z","timestamp":1208410524000},"page":"116-124","source":"Crossref","is-referenced-by-count":35,"title":["Androgen deficiency: effects on body composition"],"prefix":"10.1007","volume":"12","author":[{"given":"Karen K.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,18]]},"reference":[{"key":"121_CR1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(00)64118-1","volume":"2","author":"CE Brown-Sequard","year":"1889","unstructured":"Brown-Sequard CE (1889) Note on the effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals. Lancet 2:105\u2013107","journal-title":"Lancet"},{"key":"121_CR2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.5694\/j.1326-5377.2002.tb05014.x","volume":"177","author":"AJ Cussons","year":"2002","unstructured":"Cussons AJ, Bhagat CI, Fletcher SJ, Walsh JP (2002) Brown-Sequard revisited: a lesson from history on the placebo effect of androgen treatment. Med J Aust 177:678\u2013679","journal-title":"Med J Aust"},{"key":"121_CR3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005392-200102000-00004","volume":"165","author":"ER Freeman","year":"2001","unstructured":"Freeman ER, Bloom DA, McGuire EJ (2001) A brief history of testosterone. J Urol 165:371\u2013373. doi: 10.1097\/00005392-200102000-00004","journal-title":"J Urol"},{"key":"121_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/bchm2.1935.237.1-3.89","volume":"237","author":"A Butenandt","year":"1935","unstructured":"Butenandt A, Hanisch G (1935) Umwandlung des dehydro-androsterons in androsendiol und testosteron; ein weg zur darstellung des testosterons aus cholestrin. Hoppe Seylers Z Physiol Chem 237:89","journal-title":"Hoppe Seylers Z Physiol Chem"},{"key":"121_CR5","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/hlca.193501801176","volume":"18","author":"L Ruzicka","year":"1935","unstructured":"Ruzicka L, Wettstein A (1935) Sexualhormone VII. Uber die kunstliche herstellung des testikelhormons. Testosteron (androsten-3-on-17-ol.). Helv Chim Acta 18:1264. doi: 10.1002\/hlca.193501801176","journal-title":"Helv Chim Acta"},{"key":"121_CR6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1210\/edrv-9-2-181","volume":"9","author":"JD Wilson","year":"1988","unstructured":"Wilson JD (1988) Androgen abuse by athletes. Endocr Rev 9:181\u2013199","journal-title":"Endocr Rev"},{"key":"121_CR7","first-page":"4358","volume":"81","author":"L Katznelson","year":"1996","unstructured":"Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A (1996) Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 81:4358\u20134365. doi: 10.1210\/jc.81.12.4358","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2214\/ajr.170.2.9456958","volume":"170","author":"L Katznelson","year":"1997","unstructured":"Katznelson L, Rosenthal D, Rosol M et al (1997) Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism. AJR Am J Roentgenol 170:423\u2013427","journal-title":"AJR Am J Roentgenol"},{"key":"121_CR9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jc.2003-031492","volume":"89","author":"LJ Woodhouse","year":"2004","unstructured":"Woodhouse LJ, Gupta N, Bhasin M et al (2004) Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab 89:718\u2013726. doi: 10.1210\/jc.2003-031492","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR10","first-page":"1886","volume":"83","author":"N Mauras","year":"1998","unstructured":"Mauras N, Hayes V, Welch S et al (1998) Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 83:1886\u20131892. doi: 10.1210\/jc.83.6.1886","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR11","doi-asserted-by":"crossref","unstructured":"Galvao DA, Spry NA, Taaffe DR et\u00a0al (2008) Changes in muscle, fat and bone mass after 36\u00a0weeks of maximal androgen blockade for prostate cancer. BJU Int [Epub ahead of print]","DOI":"10.1111\/j.1464-410X.2008.07539.x"},{"key":"121_CR12","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1210\/jc.2002-021827","volume":"88","author":"BA Crawford","year":"2003","unstructured":"Crawford BA, Liu PY, Kean MT, Bleasel JF, Handelsman DJ (2003) Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment. J Clin Endocrinol Metab 88:3167\u20133176. doi: 10.1210\/jc.2002-021827","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/archinte.1996.00440100065008","volume":"156","author":"IR Reid","year":"1996","unstructured":"Reid IR, Wattie DJ, Evans MC, Stapleton JP (1996) Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 156:1173\u20131177. doi: 10.1001\/archinte.156.11.1173","journal-title":"Arch Intern Med"},{"key":"121_CR14","first-page":"3155","volume":"83","author":"S Bhasin","year":"1998","unstructured":"Bhasin S, Storer TW, Asbel-Sethi N et al (1998) Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab 83:3155\u20133162. doi: 10.1210\/jc.83.9.3155","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jama.283.6.763","volume":"283","author":"S Bhasin","year":"2000","unstructured":"Bhasin S, Storer TW, Javanbakht M et al (2000) Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 283:763\u2013770. doi: 10.1001\/jama.283.6.763","journal-title":"JAMA"},{"key":"121_CR16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-129-1-199807010-00005","volume":"129","author":"S Grinspoon","year":"1998","unstructured":"Grinspoon S, Corcoran C, Askari H et al (1998) Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 129:18\u201326","journal-title":"Ann Intern Med"},{"key":"121_CR17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-133-5-200009050-00010","volume":"133","author":"S Grinspoon","year":"2000","unstructured":"Grinspoon S, Corcoran C, Parlman K et al (2000) Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med 133:348\u2013355","journal-title":"Ann Intern Med"},{"key":"121_CR18","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/00002030-199711000-00008","volume":"11","author":"GO Coodley","year":"1997","unstructured":"Coodley GO, Coodley MK (1997) A trial of testosterone therapy for HIV-associated weight loss. AIDS 11:1347\u20131352. doi: 10.1097\/00002030-199711000-00008","journal-title":"AIDS"},{"key":"121_CR19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0002-9343(99)00193-X","volume":"107","author":"AS Dobs","year":"1999","unstructured":"Dobs AS, Cofrancesco J, Nolten WE et al (1999) The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection. Am J Med 107:126\u2013132. doi: 10.1016\/S0002-9343(99)00193-X","journal-title":"Am J Med"},{"key":"121_CR20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.qai.0000197546.56131.40","volume":"41","author":"C Grunfeld","year":"2006","unstructured":"Grunfeld C, Kotler DP, Dobs A, Glesby M, Bhasin S (2006) Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study. J Acquir Immune Defic Syndr 41:304\u2013314. doi: 10.1097\/01.qai.0000197546.56131.40","journal-title":"J Acquir Immune Defic Syndr"},{"key":"121_CR21","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1210\/jc.2005-0275","volume":"90","author":"TW Storer","year":"2005","unstructured":"Storer TW, Woodhouse LJ, Sattler F et al (2005) A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment. J Clin Endocrinol Metab 90:4474\u20134482. doi: 10.1210\/jc.2005-0275","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ncpendmet0120","volume":"2","author":"S Bhasin","year":"2006","unstructured":"Bhasin S, Calof OM, Storer TW et al (2006) Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab 2:146\u2013159. doi: 10.1038\/ncpendmet0120","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"121_CR23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","volume":"87","author":"HA Feldman","year":"2002","unstructured":"Feldman HA, Longcope C, Derby CA et al (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87:589\u2013598. doi: 10.1210\/jc.87.2.589","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","volume":"86","author":"SM Harman","year":"2001","unstructured":"Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86:724\u2013731. doi: 10.1210\/jc.86.2.724","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR25","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/jc.2004-1184","volume":"90","author":"S Bhasin","year":"2005","unstructured":"Bhasin S, Woodhouse L, Casaburi R et al (2005) Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 90:678\u2013688. doi: 10.1210\/jc.2004-1184","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR26","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2004-1933","volume":"90","author":"ST Page","year":"2005","unstructured":"Page ST, Amory JK, Bowman FD et al (2005) Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90:1502\u20131510. doi: 10.1210\/jc.2004-1933","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR27","first-page":"2647","volume":"84","author":"PJ Snyder","year":"1999","unstructured":"Snyder PJ, Peachey H, Hannoush P et al (1999) Effect of testosterone treatment on body composition and muscle strength in men over 65\u00a0years of age. J Clin Endocrinol Metab 84:2647\u20132653. doi: 10.1210\/jc.84.8.2647","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR28","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/gerona\/58.7.M618","volume":"58","author":"GA Wittert","year":"2003","unstructured":"Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE (2003) Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci 58:618\u2013625","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"121_CR29","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1001\/jama.288.18.2282","volume":"288","author":"MR Blackman","year":"2002","unstructured":"Blackman MR, Sorkin JD, Munzer T et al (2002) Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288:2282\u20132292. doi: 10.1001\/jama.288.18.2282","journal-title":"JAMA"},{"key":"121_CR30","doi-asserted-by":"crossref","first-page":"M266","DOI":"10.1093\/gerona\/56.5.M266","volume":"56","author":"AM Kenny","year":"2001","unstructured":"Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG (2001) Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 56:M266\u2013M272","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"121_CR31","first-page":"1092","volume":"75","author":"JS Tenover","year":"1992","unstructured":"Tenover JS (1992) Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 75:1092\u20131098. doi: 10.1210\/jc.75.4.1092","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR32","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1210\/jc.2002-021058","volume":"88","author":"C Steidle","year":"2003","unstructured":"Steidle C, Schwartz S, Jacoby K, Sebree T, Smith T, Bachand R (2003) AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab 88:2673\u20132681. doi: 10.1210\/jc.2002-021058","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR33","first-page":"121","volume":"60","author":"SM Harman","year":"2003","unstructured":"Harman SM, Blackman MR (2003) The effects of growth hormone and sex steroid on lean body mass, fat mass, muscle strength, cardiovascular endurance and adverse events in healthy elderly women and men. Horm Res 60:121\u2013124. doi: 10.1159\/000071236","journal-title":"Horm Res"},{"key":"121_CR34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1532-5415.1993.tb02049.x","volume":"41","author":"JE Morley","year":"1993","unstructured":"Morley JE, Perry HM III, Kaiser FE et al (1993) Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 41:149\u2013152","journal-title":"J Am Geriatr Soc"},{"key":"121_CR35","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1210\/jcem.82.6.3988","volume":"82","author":"R Sih","year":"1997","unstructured":"Sih R, Morley JE, Kaiser FE, Perry HM III, Patrick P, Ross C (1997) Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 82:1661\u20131667. doi: 10.1210\/jc.82.6.1661","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR36","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","volume":"60","author":"OM Calof","year":"2005","unstructured":"Calof OM, Singh AB, Lee ML et al (2005) Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 60:1451\u20131457","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"121_CR37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/01.CIR.78.3.539","volume":"78","author":"E Barrett-Connor","year":"1988","unstructured":"Barrett-Connor E, Khaw KT (1988) Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 78:539\u2013545","journal-title":"Circulation"},{"key":"121_CR38","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0026-0495(90)90297-P","volume":"39","author":"JC Seidell","year":"1990","unstructured":"Seidell JC, Bjorntorp P, Sjostrom L, Kvist H, Sannerstedt R (1990) Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 39:897\u2013901. doi: 10.1016\/0026-0495(90) 90297-P","journal-title":"Metabolism"},{"key":"121_CR39","first-page":"153","volume":"723","author":"B Zumoff","year":"1988","unstructured":"Zumoff B (1988) Hormonal abnormalities in obesity. Acta Med Scand Suppl 723:153\u2013160","journal-title":"Acta Med Scand Suppl"},{"key":"121_CR40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1210\/jc.2005-1326","volume":"91","author":"V Kupelian","year":"2006","unstructured":"Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91:843\u2013850. doi: 10.1210\/jc.2005-1326","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR41","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2337\/diacare.27.5.1036","volume":"27","author":"DE Laaksonen","year":"2004","unstructured":"Laaksonen DE, Niskanen L, Punnonen K et al (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27:1036\u20131041. doi: 10.2337\/diacare.27.5.1036","journal-title":"Diabetes Care"},{"key":"121_CR42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/diacare.25.1.55","volume":"25","author":"JY Oh","year":"2002","unstructured":"Oh JY, Barrett-Connor E, Wedick NM, Wingard DL (2002) Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 25:55\u201360. doi: 10.2337\/diacare.25.1.55","journal-title":"Diabetes Care"},{"key":"121_CR43","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1210\/jc.2004-0970","volume":"90","author":"DE Laaksonen","year":"2005","unstructured":"Laaksonen DE, Niskanen L, Punnonen K et al (2005) The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 90:712\u2013719. doi: 10.1210\/jc.2004-0970","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR44","first-page":"991","volume":"16","author":"P Marin","year":"1992","unstructured":"Marin P, Holmang S, Jonsson L et al (1992) The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 16:991\u2013997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"121_CR45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0002-9343(01)00833-6","volume":"111","author":"EA Whitsel","year":"2001","unstructured":"Whitsel EA, Boyko EJ, Matsumoto AM, Anawalt BD, Siscovick DS (2001) Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. Am J Med 111:261\u2013269. doi: 10.1016\/S0002-9343(01)00833-6","journal-title":"Am J Med"},{"key":"121_CR46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/jc.2007-1792","volume":"93","author":"GA Laughlin","year":"2008","unstructured":"Laughlin GA, Barrett-Connor E, Bergstrom J (2008) Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93:68\u201375. doi: 10.1210\/jc.2007-1792","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR47","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIRCULATIONAHA.107.719005","volume":"116","author":"KT Khaw","year":"2007","unstructured":"Khaw KT, Dowsett M, Folkerd E et al (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 116:2694\u20132701. doi: 10.1161\/CIRCULATIONAHA.107.719005","journal-title":"Circulation"},{"key":"121_CR48","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archinte.167.12.1252","volume":"167","author":"AB Araujo","year":"2007","unstructured":"Araujo AB, Kupelian V, Page ST, Handelsman DJ, Bremner WJ, McKinlay JB (2007) Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med 167:1252\u20131260. doi: 10.1001\/archinte.167.12.1252","journal-title":"Arch Intern Med"},{"key":"121_CR49","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCULATIONAHA.104.489088","volume":"112","author":"GD Smith","year":"2005","unstructured":"Smith GD, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman S, Elwood P (2005) Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation 112:332\u2013340. doi: 10.1161\/CIRCULATIONAHA.104.489088","journal-title":"Circulation"},{"key":"121_CR50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jc.2007-2506","volume":"93","author":"PJ Snyder","year":"2008","unstructured":"Snyder PJ (2008) Might testosterone actually reduce mortality? J Clin Endocrinol Metab 93:32\u201333. doi: 10.1210\/jc.2007-2506","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/jc.2003-030680","volume":"89","author":"KK Miller","year":"2004","unstructured":"Miller KK, Rosner W, Lee H et al (2004) Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 89:525\u2013533. doi: 10.1210\/jc.2003-030680","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","volume":"92","author":"W Rosner","year":"2007","unstructured":"Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92:405\u2013413. doi: 10.1210\/jc.2006-1864","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR53","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1210\/jc.2007-0581","volume":"92","author":"RH Fogle","year":"2007","unstructured":"Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ (2007) Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab 92:3040\u20133043. doi: 10.1210\/jc.2007-0581","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR54","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/jcem-39-6-1020","volume":"39","author":"HL Judd","year":"1974","unstructured":"Judd HL, Judd GE, Lucas WE, Yen SS (1974) Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 39:1020\u20131024","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR55","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0002-9378(74)90490-6","volume":"118","author":"HL Judd","year":"1974","unstructured":"Judd HL, Lucas WE, Yen SS (1974) Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol 118:793\u2013798","journal-title":"Am J Obstet Gynecol"},{"key":"121_CR56","first-page":"645","volume":"85","author":"GA Laughlin","year":"2000","unstructured":"Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Muhlen D (2000) Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 85:645\u2013651. doi: 10.1210\/jc.85.2.645","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR57","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM200009073431002","volume":"343","author":"JL Shifren","year":"2000","unstructured":"Shifren JL, Braunstein GD, Simon JA et al (2000) Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343:682\u2013688. doi: 10.1056\/NEJM200009073431002","journal-title":"N Engl J Med"},{"key":"121_CR58","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJM199909303411401","volume":"341","author":"W Arlt","year":"1999","unstructured":"Arlt W, Callies F, van Vlijmen JC et al (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013\u20131020. doi: 10.1056\/NEJM199909303411401","journal-title":"N Engl J Med"},{"key":"121_CR59","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0002-9378(76)90688-8","volume":"126","author":"MH Kim","year":"1976","unstructured":"Kim MH, Rosenfield RL, Dupon C (1976) The effects of dexamethasone on plasma free androgens during the normal menstrual cycle. Am J Obstet Gynecol 126:982\u2013986","journal-title":"Am J Obstet Gynecol"},{"key":"121_CR60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0378-5122(85)90018-0","volume":"7","author":"RS Mathur","year":"1985","unstructured":"Mathur RS, Landgrebe SC, Moody LO, Semmens JP, Williamson HO (1985) The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women. Maturitas 7:129\u2013133. doi: 10.1016\/0378-5122(85)90018-0","journal-title":"Maturitas"},{"key":"121_CR61","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/humrep\/15.6.1225","volume":"15","author":"J Dor","year":"2000","unstructured":"Dor J, Bider D, Shulman A et al (2000) Effects of gonadotrophin-releasing hormone agonists on human ovarian steroid secretion in vivo and in vitro-results of a prospective, randomized in-vitro fertilization study. Hum Reprod 15:1225\u20131230. doi: 10.1093\/humrep\/15.6.1225","journal-title":"Hum Reprod"},{"key":"121_CR62","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1210\/jc.2006-2501","volume":"92","author":"KK Miller","year":"2007","unstructured":"Miller KK, Lawson EA, Mathur V et al (2007) Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. J Clin Endocrinol Metab 92:1334\u20131339. doi: 10.1210\/jc.2006-2501","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR63","first-page":"2717","volume":"83","author":"K Miller","year":"1998","unstructured":"Miller K, Corcoran C, Armstrong C et al (1998) Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. J Clin Endocrinol Metab 83:2717\u20132725. doi: 10.1210\/jc.83.8.2717","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR64","first-page":"1429","volume":"80","author":"B Zumoff","year":"1995","unstructured":"Zumoff B, Strain GW, Miller LK, Rosner W (1995) Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 80:1429\u20131430. doi: 10.1210\/jc.80.4.1429","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR65","first-page":"561","volume":"86","author":"KK Miller","year":"2001","unstructured":"Miller KK, Sesmilo G, Schiller A, Schoenfeld D, Burton S, Klibanski A (2001) Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab 86:561\u2013567. doi: 10.1210\/jc.86.2.561","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR66","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/archinte.164.8.897","volume":"164","author":"S Dolan","year":"2004","unstructured":"Dolan S, Wilkie S, Aliabadi N et al (2004) Effects of testosterone administration in human immunodeficiency virus-infected women with low weight: a randomized placebo-controlled study. Arch Intern Med 164:897\u2013904. doi: 10.1001\/archinte.164.8.897","journal-title":"Arch Intern Med"},{"key":"121_CR67","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1210\/jc.2004-1677","volume":"90","author":"HH Choi","year":"2005","unstructured":"Choi HH, Gray PB, Storer TW et al (2005) Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss. J Clin Endocrinol Metab 90:1531\u20131541. doi: 10.1210\/jc.2004-1677","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR68","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1210\/jc.2005-2596","volume":"91","author":"KK Miller","year":"2006","unstructured":"Miller KK, Biller BM, Beauregard C et al (2006) Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 91:1683\u20131690. doi: 10.1210\/jc.2005-2596","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR69","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1210\/jc.2007-0195","volume":"92","author":"KK Miller","year":"2007","unstructured":"Miller KK, Biller BM, Schaub A et al (2007) Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism. J Clin Endocrinol Metab 92:2474\u20132479. doi: 10.1210\/jc.2007-0195","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR70","first-page":"3469","volume":"81","author":"IG Brodsky","year":"1996","unstructured":"Brodsky IG, Balagopal P, Nair KS (1996) Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men\u2014a clinical research center study. J Clin Endocrinol Metab 81:3469\u20133475. doi: 10.1210\/jc.81.10.3469","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR71","first-page":"E820","volume":"269","author":"RJ Urban","year":"1995","unstructured":"Urban RJ, Bodenburg YH, Gilkison C et al (1995) Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 269:E820\u2013E826","journal-title":"Am J Physiol"},{"key":"121_CR72","doi-asserted-by":"crossref","first-page":"E154","DOI":"10.1152\/ajpendo.00502.2001","volume":"283","author":"I Sinha-Hikim","year":"2002","unstructured":"Sinha-Hikim I, Artaza J, Woodhouse L et al (2002) Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab 283:E154\u2013E164","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"121_CR73","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1210\/jcem.87.1.8172","volume":"87","author":"AB Singh","year":"2002","unstructured":"Singh AB, Hsia S, Alaupovic P et al (2002) The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab 87:136\u2013143. doi: 10.1210\/jc.87.1.136","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR74","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/en.2004-1649","volume":"147","author":"R Singh","year":"2006","unstructured":"Singh R, Artaza JN, Taylor WE et al (2006) Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147:141\u2013154. doi: 10.1210\/en.2004-1649","journal-title":"Endocrinology"},{"key":"121_CR75","doi-asserted-by":"crossref","first-page":"M1103","DOI":"10.1093\/gerona\/58.12.M1103","volume":"58","author":"S Bhasin","year":"2003","unstructured":"Bhasin S, Taylor WE, Singh R et al (2003) The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action. J Gerontol A Biol Sci Med Sci 58:M1103\u2013M1110","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"121_CR76","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/jc.2005-2847","volume":"91","author":"S Bhasin","year":"2006","unstructured":"Bhasin S, Cunningham GR, Hayes FJ et al (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91:1995\u20132010. doi: 10.1210\/jc.2005-2847","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR77","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archinte.165.14.1582","volume":"165","author":"GD Braunstein","year":"2005","unstructured":"Braunstein GD, Sundwall DA, Katz M et al (2005) Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 165:1582\u20131589. doi: 10.1001\/archinte.165.14.1582","journal-title":"Arch Intern Med"},{"key":"121_CR78","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/01.AOG.0000158103.27672.0d","volume":"105","author":"JE Buster","year":"2005","unstructured":"Buster JE, Kingsberg SA, Aguirre O et al (2005) Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 105:944\u2013952","journal-title":"Obstet Gynecol"},{"key":"121_CR79","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.gme.0000179049.08371.c7","volume":"13","author":"SR Davis","year":"2006","unstructured":"Davis SR, van der Mooren MJ, van Lunsen RH et al (2006) Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause 13:387\u2013396. doi: 10.1097\/01.gme.0000179049.08371.c7","journal-title":"Menopause"},{"key":"121_CR80","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1210\/jc.2004-1747","volume":"90","author":"J Simon","year":"2005","unstructured":"Simon J, Braunstein G, Nachtigall L et al (2005) Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 90:5226\u20135233. doi: 10.1210\/jc.2004-1747","journal-title":"J Clin Endocrinol Metab"},{"key":"121_CR81","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.gme.0000227400.60816.52","volume":"13","author":"JL Shifren","year":"2006","unstructured":"Shifren JL, Davis SR, Moreau M et al (2006) Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 13:770\u2013779. doi: 10.1097\/01.gme.0000227400.60816.52","journal-title":"Menopause"},{"key":"121_CR82","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1210\/jc.2006-1121","volume":"91","author":"ME Wierman","year":"2006","unstructured":"Wierman ME, Basson R, Davis SR et al (2006) Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 91:3697\u20133710. doi: 10.1210\/jc.2006-1121","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-008-0121-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-008-0121-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-008-0121-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T11:59:00Z","timestamp":1588593540000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-008-0121-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,18]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["121"],"URL":"https:\/\/doi.org\/10.1007\/s11102-008-0121-7","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,18]]}}}